Your browser doesn't support javascript.
loading
Outcomes following antegrade-only versus retrograde chronic total occlusion percutaneous coronary intervention: insights from the CCTOP registry.
Verreault-Julien, Louis; Jahan, Israth; Dendukuri, Nandini; Ybarra, Luiz F; Mansour, Samer; Matteau, Alexis; Wijeysundera, Harindra C; Fung, Anthony; Robinson, Simon; Paradis, Jean-Michel; Nguyen, Can Manh; Rinfret, Stéphane.
  • Verreault-Julien L; St. Francis - Emory Healthcare, Columbus, Georgia, USA.
  • Jahan I; McGill University Health Centre, Montreal, Quebec, Canada.
  • Dendukuri N; McGill University Health Centre, Montreal, Quebec, Canada.
  • Ybarra LF; McGill University Health Centre, Montreal, Quebec, Canada.
  • Mansour S; Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
  • Matteau A; Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
  • Wijeysundera HC; Schulich Heart Centre, Division of Cardiology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Fung A; Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Robinson S; Division of Cardiology, Royal Jubilee Hospital, University of British Columbia, Victoria, British Columbia, Canada; Victoria Heart Institute Foundation, Victoria, British Columbia, Canada.
  • Paradis JM; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Québec, Canada.
  • Nguyen CM; Victoria Heart Institute Foundation, Victoria, British Columbia, Canada.
  • Rinfret S; McGill University Health Centre, Montreal, Quebec, Canada; Georgia Heart Institute, Northeast Georgia Medical Center, Gainesville, Georgia, USA. Email: srinfret@me.com.
J Invasive Cardiol ; 2024 08 19.
Article en En | MEDLINE | ID: mdl-39172884
ABSTRACT

Background:

Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) can be performed using an antegrade-only (AO) approach or a retrograde approach (RA). Whether an RA carries a higher risk of complications needs further investigation.

Methods:

The Canadian CTO PCI (CCTOP) was a multicenter, prospective, investigator-initiated cohort study conducted at 6 experienced centers across Canada between March 2014 and October 2019. Patients who underwent an RA were compared to AO patients. The primary endpoint was in-hospital major adverse cardiac events (MACE), defined as death, any post-PCI cardiac enzyme elevation, urgent revascularization, and tamponade. A multivariable analysis was performed to control for potential confounders.

Results:

A total of 1033 patients were included in the study, and an RA was used in 48.4% of the cases. The RA was associated with higher lesions complexity (J-CTO score 2.7 ± 1.1 vs 2.3 ± 1.1, P < .001) and lower technical success (81.2% vs 91.5%, P < .001). The risk of in-hospital MACE was higher with the RA (10.2% vs 4.7%, P < .001), and all deaths occurred in the RA group (0.8% vs 0%, P = .038). In the multivariable model, the RA remained associated with an increased risk of MACE (OR, 2.25; 95% CI, 1.26 to 4.02).

Conclusions:

Our experience confirms that the RA is associated with an independent increased risk of in-hospital MACE when compared with an AO approach.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article